0:55

In this segment, the speaker critiques the current standard of care for depression and PTSD, which relies heavily on selective serotonin reuptake inhibitors (SSRIs) such as Paxil and Zoloft. While acknowledging that SSRIs can provide short‑term stabilization, the speaker emphasizes their poor long‑term outcomes: over 70% of PTSD patients never achieve lasting remission, and even when SSRIs appear effective, about 80% of patients relapse after discontinuation, leading to a lifelong diagnosis. The discussion then introduces MDMA as a potential alternative therapeutic approach, suggesting that it may address the shortcomings of SSRIs, though the excerpt does not detail its efficacy.

Chapters

More from Claudia

youtube.com

Why Sauna Can Make You Feel Worse | Detox Done Right

7mo ago
youtube.com

Longevity Isn’t About Perfection | Small Daily Upgrades Matter

7mo ago
youtube.com

The Right Way to Do Keto | Avoid Metabolic Mistakes

7mo ago
youtube.com

You’re Rusting From the Inside | Oxidative Stress Explained

7mo ago
youtube.com

Your Arteries Are Rusting — Here’s How to Reverse It | Dr. Chris Davis

7mo ago
youtube.com

The Revolving Door of Cardiology | Managing vs Preventing Heart Disease

7mo ago
youtube.com

Were We Misled About Psychedelics?

7mo ago
youtube.com

What Psilocin Does Inside Your Cells

7mo ago
youtube.com

Can Psilocybin Slow Aging? The Study on Telomeres, Inflammation & Survival with Dr. Louise Hecker

7mo ago
youtube.com

Psilocybin & Wound Healing?!

7mo ago
youtube.com

Life Is Just a Series of Nows | Presence & Nervous System Regulation

7mo ago
See all content